Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.
2.

Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.

Kabalka GW, Smith GT, Dyke JP, Reid WS, Longford CP, Roberts TG, Reddy NK, Buonocore E, Hübner KF.

J Nucl Med. 1997 Nov;38(11):1762-7.

3.

The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma.

Kabalka GW, Nichols TL, Smith GT, Miller LF, Khan MK, Busse PM.

J Neurooncol. 2003 Mar-Apr;62(1-2):187-95.

PMID:
12749713
4.

Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.

Coderre JA, Elowitz EH, Chadha M, Bergland R, Capala J, Joel DD, Liu HB, Slatkin DN, Chanana AD.

J Neurooncol. 1997 May;33(1-2):141-52.

PMID:
9151231
5.

Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.

Chadha M, Capala J, Coderre JA, Elowitz EH, Iwai J, Joel DD, Liu HB, Wielopolski L, Chanana AD.

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):829-34.

PMID:
9531367
6.

Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.

Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R.

Clin Cancer Res. 1998 Aug;4(8):1833-41.

7.

Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.

Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R.

Clin Cancer Res. 1998 Aug;4(8):1825-32.

8.

Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.

Miyatake S, Kawabata S, Kajimoto Y, Aoki A, Yokoyama K, Yamada M, Kuroiwa T, Tsuji M, Imahori Y, Kirihata M, Sakurai Y, Masunaga S, Nagata K, Maruhashi A, Ono K.

J Neurosurg. 2005 Dec;103(6):1000-9.

PMID:
16381186
9.

PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.

Nariai T, Ishiwata K, Kimura Y, Inaji M, Momose T, Yamamoto T, Matsumura A, Ishii K, Ohno K.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S348-50. doi: 10.1016/j.apradiso.2009.03.061. Epub 2009 Mar 27.

PMID:
19375930
11.

Boron neutron capture therapy of brain tumors: past history, current status, and future potential.

Barth RF, Soloway AH, Brugger RM.

Cancer Invest. 1996;14(6):534-50. Review.

PMID:
8951358
12.

Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data.

Zamenhof R, Redmond E 2nd, Solares G, Katz D, Riley K, Kiger S, Harling O.

Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):383-97.

PMID:
8635948
13.

Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.

Joel DD, Coderre JA, Micca PL, Nawrocky MM.

J Neurooncol. 1999 Feb;41(3):213-21.

PMID:
10359141
14.

Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).

Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT; Swedish Brain Tumour Study Group.

Radiother Oncol. 2008 Aug;88(2):183-91. doi: 10.1016/j.radonc.2006.04.015. Epub 2008 Mar 11.

PMID:
18336940
15.

Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.

Menichetti L, Cionini L, Sauerwein WA, Altieri S, Solin O, Minn H, Salvadori PA.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S351-4. doi: 10.1016/j.apradiso.2009.03.062. Epub 2009 Apr 2.

PMID:
19410471
16.

Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.

Wang HE, Liao AH, Deng WP, Chang PF, Chen JC, Chen FD, Liu RS, Lee JS, Hwang JJ.

J Nucl Med. 2004 Feb;45(2):302-8.

17.

Boron neutron capture therapy of primary and metastatic brain tumors.

Barth RF, Soloway AH.

Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):139-54. Review.

PMID:
8086033
18.

Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.

Morris GM, Micca PL, Nawrocky MM, Weissfloch LE, Coderre JA.

Radiat Res. 2002 Dec;158(6):743-52.

PMID:
12452777
19.

Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.

Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):209-18.

PMID:
10758326
20.

Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine.

Joensuu H, Kankaanranta L, Seppälä T, Auterinen I, Kallio M, Kulvik M, Laakso J, Vähätalo J, Kortesniemi M, Kotiluoto P, Serén T, Karila J, Brander A, Järviluoma E, Ryynänen P, Paetau A, Ruokonen I, Minn H, Tenhunen M, Jääskeläinen J, Färkkilä M, Savolainen S.

J Neurooncol. 2003 Mar-Apr;62(1-2):123-34.

PMID:
12749708

Supplemental Content

Support Center